Pharmaceuticals UltraSector ProFund

The Pharmaceuticals UltraSector ProFund seeks daily investment results, before fees and expenses, that are 1.5x the return of the Dow Jones U.S. PharmaceuticalsSM Index (the "Index") for a single day.

Fund Snapshot

Investor Class Service Class
CUSIP 743185423 743185415
Fund Number 047 077
Inception Date 6/28/2000
Fund Group Sector ProFunds - UltraSector

Fund Statistics

Limits On Exchanges None
Minimum Investment
Individual Investor $15,000
Financial Professionals $5,000

NAV as of 2/16/2018

Class NAV % Change $ Change
Investor $24.37 1.50% $0.36 NAV History
Service $21.57 1.51% $0.32 NAV History
PHPIX Current Quote and Chart

Returns (as of 12/31/2017)

Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than the original cost.

For standardized returns year-to-date, and as of the most recent calendar quarter-end, and annualized month-end, see performance. Returns include the reinvestment of dividends and capital gains.

YTD (as of 2/16/2018) -1.18%
Average Annual One Year 15.04%
Average Annual Three Year 4.47%
Average Annual Five Year 17.39%
Average Annual Ten Year 10.99%
Average Annual Since Inception 2.40%
Cumulative Since Inception 51.59%
Gross Expense Ratio 1.74%
Net Expense Ratio * 1.74%

* Contractual waiver effective from December 1, 2017 through November 30, 2018. Without such a waiver of fees, the total returns may have been lower.

All data, unless otherwise noted, is as of 12/31/2017 and for Investor Class Shares only and is subject to change.


Dow Jones U.S. Pharmaceuticals Index

The Index (Bloomberg symbol: DJUSPR) measures the performance of the pharmaceuticals sector of the U.S. equity market. Component companies include, among others, the makers of prescription and over-the-counter drugs, such as birth control pills, vaccines, aspirin and cold remedies. It is not possible to invest directly in an index.

Total Index Companies 20
Price/Earnings Ratio 20.96
Price/Book Ratio 3.60
Dividend Yield 2.54%
Average Index Market Capitalization 54.93 billion

Index as of 12/29/2017

Index Sector Weightings Weight
Pharmaceuticals 99.71%
Biotechnology 0.29%

Index as of 12/29/2017

Top 10 Index Companies Weight
Johnson & Johnson 34.63%
Pfizer Inc. 19.92%
Merck & Co. Inc. 14.20%
Bristol-Myers Squibb Co. 9.25%
Eli Lilly & Co. 7.55%
Allergan PLC 5.02%
Zoetis Inc. 3.24%
Mylan NV 2.09%
Perrigo Co. PLC 1.05%
Jazz Pharmaceuticals PLC 0.74%